Literature DB >> 6129382

Genetic susceptibility to scleroderma-like syndrome induced by vinyl chloride.

C M Black, K I Welsh, A E Walker, R M Bernstein, L J Catoggio, A R McGregor, J K Jones.   

Abstract

Vinyl chloride (VC) monomer can induce a scleroderma-like syndrome in a proportion of workers exposed to it during production of polyvinyl chloride. As part of a 5-year follow-up study HLA A, B, and DR antigens and anti-centromere and anti-scleroderma-70 antibodies were determined in 44 such workers. 21 of these had severe and 23 mild forms of vinyl-chloride disease. 50 patients with "classical" scleroderma and 148 healthy hospital workers acted as controls. 11 of the 21 patients classified as having severe VC disease were DR3 positive, and 8 of these had both B8 and DR3 antigens. None of the 23 patients with mild disease carried either antigen. The HLA-antigen frequencies in VC disease mirrored those found in scleroderma (raised DR5 frequency and increased linkage disequilibrium between B8 and DR3). There were, however, significant differences in the frequency of autoantibodies in the two conditions.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6129382     DOI: 10.1016/s0140-6736(83)91578-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  11 in total

Review 1.  Immunotoxicology: suppressive and stimulatory effects of drugs and environmental chemicals on the immune system. A discussion.

Authors:  E Gleichmann; I Kimber; I F Purchase
Journal:  Arch Toxicol       Date:  1989       Impact factor: 5.153

Review 2.  Epidemiology of scleroderma.

Authors:  A J Silman
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

Review 3.  Major histocompatibility complex class II genes and systemic sclerosis.

Authors:  D Briggs; K I Welsh
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

4.  Type 1 diabetes mellitus, celiac disease, systemic lupus erythematosus and systemic scleroderma in a 15-year-old girl.

Authors:  Héla Zeglaoui; Hanène Landolsi; Amani Mankai; Ibtissem Ghedira; Elyès Bouajina
Journal:  Rheumatol Int       Date:  2009-06-09       Impact factor: 2.631

5.  Source of infection in Hickman catheters.

Authors:  N C Weightman; E M Simpson; D C Speller
Journal:  J Clin Pathol       Date:  1986-09       Impact factor: 3.411

6.  Chronic juvenile toxic epidemic syndrome.

Authors:  M Izquierdo; I Mateo; M Rodrígo; C Mena; M Sebastián; J Conde; J J Gómez-Reino
Journal:  Ann Rheum Dis       Date:  1985-02       Impact factor: 19.103

Review 7.  Clinical aspects of systemic sclerosis (scleroderma).

Authors:  R M Silver
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

8.  Systemic sclerosis in Iceland. A nationwide epidemiological study.

Authors:  A J Geirsson; K Steinsson; S Guthmundsson; V Sigurthsson
Journal:  Ann Rheum Dis       Date:  1994-08       Impact factor: 19.103

9.  Regressive systemic sclerosis.

Authors:  C Black; P Dieppe; T Huskisson; F D Hart
Journal:  Ann Rheum Dis       Date:  1986-05       Impact factor: 19.103

Review 10.  Organic solvents as risk factor for autoimmune diseases: a systematic review and meta-analysis.

Authors:  Carolina Barragán-Martínez; Cesar A Speck-Hernández; Gladis Montoya-Ortiz; Rubén D Mantilla; Juan-Manuel Anaya; Adriana Rojas-Villarraga
Journal:  PLoS One       Date:  2012-12-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.